Sovereign makes changes to health cover

Len Elikhis

Sovereign chief officer product, Len Elikhis, says the changes are a "modernisation" of its health policy to bring them into line with customers' expectations.

While there are a number of changes the key one is around its cover of cancer care. It is extending cover for chemotherapy treatments approved by Medsafe but not funded by Pharmac, and these are also being made to Sovereign's legacy products

Ongoing medical advancements are creating the need for health insurance products to evolve to ensure New Zealanders benefit from the improvements. In response to medical advancements.

The enhancements give Sovereign health customers a range of increased benefits including access to unlimited surgical cover, extended cancer care, treatment anywhere in the world, along with a range of benefits designed to support customer’s pre and post treatment.